AIM ImmunoTech (AIM) Intangibles (2010 - 2026)
AIM ImmunoTech's (AIM) quarterly Intangibles came in at $35000.0 in Q1 2026, down 98.46% YoY from $2.3 million in Q1 2025, and down 98.5% on a QoQ basis from $2.3 million in Q4 2025.
AIM ImmunoTech (AIM) Intangibles (2010 - 2026) Analysis & Trends
AIM ImmunoTech (AIM) has 17 years of Intangibles data on file, last reported at $35000.0 in Q1 2026.
- Quarterly Intangibles fell 98.46% year-over-year to $35000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $35000.0 (down 98.46% YoY) and the FY2025 annual result came in at $2.3 million, down 10.1% from the prior year.
- Intangibles fell to $35000.0 in Q1 2026, from $2.3 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $3.0 million in Q3 2025 to a low of $33000.0 in Q1 2022.
- A 5-year average of $1.4 million and a median of $1.9 million in 2022 frame the typical range for Intangibles.
- Annual changes were most pronounced in 2023 — Intangibles soared 5651.52% — and 2026, when it plunged 98.46%.
- Tracing AIM's Intangibles over 5 years: stood at $1.9 million in 2022, then gained by 19.17% to $2.3 million in 2023, then climbed by 12.15% to $2.6 million in 2024, then dropped by 10.1% to $2.3 million in 2025, then plunged by 98.5% to $35000.0 in 2026.
- The last three Intangibles figures came in at $35000.0 (Q1 2026), $2.3 million (Q4 2025), and $3.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.35 Bn | 131.49 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 86.24 Bn | 78.25 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.08 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 58.83 Bn | 53.69 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.50 Bn | 26.34 Bn | 358.27 Mn | 93.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.44 Bn | - | - |
| 10 | AIM ImmunoTech | 4.47 Mn | -5.49 Mn | 21,000.00 | 147,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 147,000.00 |
| Mar 31, 2026 | 35,000.00 |
| Dec 31, 2025 | 2.33 Mn |
| Sep 30, 2025 | 2.99 Mn |
| Jun 30, 2025 | 283,000.00 |
| Mar 31, 2025 | 2.27 Mn |
| Dec 31, 2024 | 2.59 Mn |
| Sep 30, 2024 | 419,000.00 |
| Jun 30, 2024 | 282,000.00 |
| Mar 31, 2024 | 50,000.00 |
| Dec 31, 2023 | 2.31 Mn |
| Sep 30, 2023 | 2.15 Mn |
| Jun 30, 2023 | 2.04 Mn |
| Mar 31, 2023 | 1.90 Mn |
| Dec 31, 2022 | 1.94 Mn |
| Sep 30, 2022 | 96,000.00 |
| Jun 30, 2022 | 2.01 Mn |
| Mar 31, 2022 | 33,000.00 |
| Dec 31, 2021 | 1.97 Mn |
| Sep 30, 2021 | 444,000.00 |